Hypertrophic Herpes Simplex Infections: successful adjuvant treatment with topical imiquimod

Authors

  • Pichanee Chaweekulrat DEPARTMENT OF DERMATOLOGY, FACULTY OF MEDICINE SIRIRAJ HOSPITAL, BANGKOK, THAILAND.
  • Charussri Leeyaphan DEPARTMENT OF DERMATOLOGY, FACULTY OF MEDICINE SIRIRAJ HOSPITAL, BANGKOK, THAILAND.

Keywords:

Hypertrophic herpes simplex infection, HIV infection, Imiquimod

Abstract

CHAWEEKULRAT P, LEEYAPHAN C. HYPERTROPHIC HERPES INFECTIONS: A CASE REPORT. THAI J DERMATOL 2020; 36: 1-6.

DEPARTMENT OF DERMATOLOGY, FACULTY OF MEDICINE SIRIRAJ HOSPITAL, BANGKOK, THAILAND.

Genital hypertrophic herpes simplex infections, atypical presentations of herpes simplex virus infections, are commonly found in immunocompromised patients, particularly human immunodeficiency virus-infected patients, and hematologic disease patients. The first-line treatment for hypertrophic genital herpes infections is thymidine kinase-dependent antiviral drugs, such as acyclovir and valacyclovir. However, the clinical course of hypertrophic herpes is usually chronic with frequent relapses, and the disease is refractory to conventional treatment. Other medications for use with resistant herpes infections are foscarnet and imiquimod. We report a case of a male patient with human immunodeficiency virus infection who presented with a progressive hypertrophic genital herpes infection in the left scrotum, which improved after treatment with acyclovir and imiquimod.

References

Leeyaphan C, Surawan TM, Chirachanakul P, et al. Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study. Int J Infect Dis 2015; 33: 165-70.

Dua P, Shinder R, Laskar DB, Lazzaro DR, Rizzuti AE. A case of hypertrophic herpes simplex virus affecting the eyelid and cornea masquerading as IgG4-related disease. Am J Ophthalmol Case Rep 2017; 9: 68-71.

Chiu CY, Randhawa G, Nada K, Tomczak E, Feinstein A, Hennessey K. A nasal hypertrophic lesion as a presentation of herpes simplex virus. IDCases 2019; 15: e00512.

Abbo L, Vincek V, Dickinson G, Shrestha N, Doblecki S, Haslett PA. Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod. Clin Infect Dis 2007; 44: e25-7.

Nieto Rodriguez D, Sendagorta Cudos E, Rueda Carnero JM, Herranz Pinto P. Atypical Presentation of Herpes Simplex Virus Type 2 Infection Refractory to Treatment With Aciclovir in 2 Hematologic Patients. Actas Dermosifiliogr 2019; 110: 393-7.

Hanjani NM, Foster DC, Scott GA, Mercurio MG. A genital mass due to herpes simplex virus in a renal transplant recipient. J Low Genit Tract Dis 2007; 11: 173-6.

McKendry A, Narayana S, Browne R. Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod. Int J STD AIDS 2015; 26: 441-3.

Miller RL, Tomai MA, Harrison CJ, Bernstein DI. Immunomodulation as a treatment strategy for genital herpes: review of the evidence. Int Immunopharmacol 2002; 2: 443-51.

Rosenblatt A, de Campos Guidi HG. Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases. Int J STD AIDS 2012; 23: 909-10.

Moore RA, Edwards JE, Hopwood J, Hicks D. Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis 2001; 1: 3.

Downloads

Published

2020-03-18

How to Cite

Chaweekulrat, P., & Leeyaphan, C. (2020). Hypertrophic Herpes Simplex Infections: successful adjuvant treatment with topical imiquimod. Thai Journal of Dermatology, 36(1), 1–6. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/216390

Issue

Section

Case Report